KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for ClearPoint Neuro (CLPT) over the last 10 years, with Q3 2025 value amounting to $28.4 million.

  • ClearPoint Neuro's Shares Outstanding (Diluted Average) rose 302.97% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year increase of 302.97%. This contributed to the annual value of $27.0 million for FY2024, which is 984.54% up from last year.
  • ClearPoint Neuro's Shares Outstanding (Diluted Average) amounted to $28.4 million in Q3 2025, which was up 302.97% from $28.3 million recorded in Q2 2025.
  • ClearPoint Neuro's Shares Outstanding (Diluted Average)'s 5-year high stood at $28.4 million during Q3 2025, with a 5-year trough of $18.9 million in Q1 2021.
  • In the last 5 years, ClearPoint Neuro's Shares Outstanding (Diluted Average) had a median value of $24.6 million in 2023 and averaged $24.8 million.
  • In the last 5 years, ClearPoint Neuro's Shares Outstanding (Diluted Average) surged by 2561.75% in 2022 and then surged by 54.11% in 2023.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Shares Outstanding (Diluted Average) stood at $20.7 million in 2021, then increased by 16.63% to $24.2 million in 2022, then grew by 1.75% to $24.6 million in 2023, then grew by 9.85% to $27.0 million in 2024, then increased by 5.18% to $28.4 million in 2025.
  • Its last three reported values are $28.4 million in Q3 2025, $28.3 million for Q2 2025, and $27.7 million during Q1 2025.